Cyclooxygenase-2 regulates mesenchymal cell differentiation into the osteoblast lineage and is critically involved in bone repair.
Journal: 2002/June - Journal of Clinical Investigation
ISSN: 0021-9738
Abstract:
Preclinical and clinical studies suggest a possible role for cyclooxygenases in bone repair and create concerns about the use of nonsteroidal antiinflammatory drugs in patients with skeletal injury. We utilized wild-type, COX-1(-/-), and COX-2(-/-) mice to demonstrate that COX-2 plays an essential role in both endochondral and intramembranous bone formation during skeletal repair. The healing of stabilized tibia fractures was significantly delayed in COX-2(-/-) mice compared with COX-1(-/-) and wild-type controls. The histology was characterized by a persistence of undifferentiated mesenchyme and a marked reduction in osteoblastogenesis that resulted in a high incidence of fibrous nonunion in the COX-2(-/-) mice. Similarly, intramembranous bone formation on the calvaria was reduced 60% in COX-2(-/-) mice following in vivo injection of FGF-1 compared with either COX-1(-/-) or wild-type mice. To elucidate the mechanism involved in reduced bone formation, osteoblastogenesis was studied in bone marrow stromal cell cultures obtained from COX-2(-/-) and wild-type mice. Bone nodule formation was reduced 50% in COX-2(-/-) mice. The defect in osteogenesis was completely rescued by addition of prostaglandin E2 (PGE(2)) to the cultures. In the presence of bone morphogenetic protein (BMP-2), bone nodule formation was enhanced to a similar level above that observed with PGE(2) alone in both control and COX-2(-/-) cultures, indicating that BMPs complement COX-2 deficiency and are downstream of prostaglandins. Furthermore, we found that the defect in COX-2(-/-) cultures correlated with significantly reduced levels of cbfa1 and osterix, two genes necessary for bone formation. Addition of PGE(2) rescued this defect, while BMP-2 enhanced cbfa1 and osterix in both COX-2(-/-) and wild-type cultures. Finally, the effects of these agents were additive, indicating that COX-2 is involved in maximal induction of osteogenesis. These results provide a model whereby COX-2 regulates the induction of cbfa1 and osterix to mediate normal skeletal repair.
Relations:
Content
Citations
(162)
References
(47)
Drugs
(1)
Chemicals
(5)
Genes
(2)
Organisms
(2)
Processes
(6)
Anatomy
(3)
Affiliates
(1)
Similar articles
Articles by the same authors
Discussion board
J Clin Invest 109(11): 1405-1415

Cyclooxygenase-2 regulates mesenchymal cell differentiation into the osteoblast lineage and is critically involved in bone repair

The Center for Musculoskeletal Research, University of Rochester Medical Center, and Department of Medicine/Endocrinology, University of Rochester School of Medicine and Dentistry, Rochester, New York, USA
Address correspondence to: Regis J. O’Keefe, The Center for Musculoskeletal Research, University of Rochester Medical Center, 601 Elmwood Avenue, Rochester, New York 14642, USA. Phone: (716) 273-4255; Fax: (716) 442-3214; E-mail: ude.retsehcor.CMRU@efeeKO;f5000x#&sigeR.
Address correspondence to: Regis J. O’Keefe, The Center for Musculoskeletal Research, University of Rochester Medical Center, 601 Elmwood Avenue, Rochester, New York 14642, USA. Phone: (716) 273-4255; Fax: (716) 442-3214; E-mail: ude.retsehcor.CMRU@efeeKO;f5000x#&sigeR.

Abstract

Preclinical and clinical studies suggest a possible role for cyclooxygenases in bone repair and create concerns about the use of nonsteroidal antiinflammatory drugs in patients with skeletal injury. We utilized wild-type, COX-1–/–, and COX-2–/– mice to demonstrate that COX-2 plays an essential role in both endochondral and intramembranous bone formation during skeletal repair. The healing of stabilized tibia fractures was significantly delayed in COX-2–/– mice compared with COX-1–/– and wild-type controls. The histology was characterized by a persistence of undifferentiated mesenchyme and a marked reduction in osteoblastogenesis that resulted in a high incidence of fibrous nonunion in the COX-2–/– mice. Similarly, intramembranous bone formation on the calvaria was reduced 60% in COX-2–/– mice following in vivo injection of FGF-1 compared with either COX-1–/– or wild-type mice. To elucidate the mechanism involved in reduced bone formation, osteoblastogenesis was studied in bone marrow stromal cell cultures obtained from COX-2–/– and wild-type mice. Bone nodule formation was reduced 50% in COX-2–/– mice. The defect in osteogenesis was completely rescued by addition of prostaglandin E2 (PGE2) to the cultures. In the presence of bone morphogenetic protein (BMP-2), bone nodule formation was enhanced to a similar level above that observed with PGE2 alone in both control and COX-2–/– cultures, indicating that BMPs complement COX-2 deficiency and are downstream of prostaglandins. Furthermore, we found that the defect in COX-2–/– cultures correlated with significantly reduced levels of cbfa1 and osterix, two genes necessary for bone formation. Addition of PGE2 rescued this defect, while BMP-2 enhanced cbfa1 and osterix in both COX-2–/– and wild-type cultures. Finally, the effects of these agents were additive, indicating that COX-2 is involved in maximal induction of osteogenesis. These results provide a model whereby COX-2 regulates the induction of cbfa1 and osterix to mediate normal skeletal repair.

Abstract

Acknowledgments

This work was supported by research grants from the Orthopedic Research Education Foundation, the Musculoskeletal Transplant Foundation, and the NIH (AR-45971 and AR-46545). The authors thank F. Abuzzahab, M. Ulrich-Vinther, L.M. Flick, and P. Tiyapatanaputi for scoring the x-rays; B.F. Boyce and L. Xing for helpful discussion of this work; and J. Harvey for her assistance with histological work.

Acknowledgments

References

  • 1. Kawaguchi H, et al Regulation of the two prostaglandin G/H synthases by parathyroid hormone, interleukin-1, cortisol, and prostaglandin E2 in cultured neonatal mouse calvariae. Endocrinology. 1994;135:1157–1164.[PubMed][Google Scholar]
  • 2. Raisz LGPhysiologic and pathologic roles of prostaglandins and other eicosanoids in bone metabolism. J Nutr. 1995;125:2024S–2027S.[PubMed][Google Scholar]
  • 3. Raisz LGProstaglandins and bone: physiology and pathophysiology. Osteoarthritis Cartilage. 1999;7:419–421.[PubMed][Google Scholar]
  • 4. Okada Y, et al Prostaglandin G/H synthase-2 is required for maximal formation of osteoclast-like cells in culture. J Clin Invest. 2000;105:823–832.[Google Scholar]
  • 5. Zhang X, et al Evidence for a direct role of COX-2 in implant wear debris induced osteolysis. J Bone Miner Res. 2001;16:660–669.[PubMed][Google Scholar]
  • 6. Weinreb M, Suponitzky I, Keila SSystemic administration of an anabolic dose of PGE2in young rats increases the osteogenic capacity of bone marrow. Bone. 1997;20:521–526.[PubMed][Google Scholar]
  • 7. Suponitzky I, Weinreb MDifferential effects of systemic prostaglandin E2 on bone mass in rat long bones and calvariae. J Endocrinol. 1998;156:51–57.[PubMed][Google Scholar]
  • 8. Forwood MRInducible cyclo-oxygenase (COX-2) mediates the induction of bone formation by mechanical loading in vivo. J Bone Miner Res. 1996;11:1688–1693.[PubMed][Google Scholar]
  • 9. Duncan RL, Turner CHMechanotransduction and the functional response of bone to mechanical strain. Calcif Tissue Int. 1995;57:344–358.[PubMed][Google Scholar]
  • 10. Morham SG, et al Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse. Cell. 1995;83:473–482.[PubMed][Google Scholar]
  • 11. Langenbach R, et al Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacin-induced gastric ulceration. Cell. 1995;83:483–492.[PubMed][Google Scholar]
  • 12. Okada Y, et al Effects of cyclooxygenase-2 gene disruption on osteoblastic function. J Bone Miner Res. 2000;15(Suppl.):217.[PubMed][Google Scholar]
  • 13. Ducy P, Zhang R, Geoffroy V, Ridall AL, Karsenty GOsf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell. 1997;89:747–754.[PubMed][Google Scholar]
  • 14. Komori T, et al Targeted disruption of cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell. 1997;89:755–764.[PubMed][Google Scholar]
  • 15. Nakashima K, et al The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation. Cell. 2002;108:17–29.[PubMed][Google Scholar]
  • 16. Dekel S, Lenthall G, Francis MJ. Release of prostaglandins from bone and muscle after tibial fracture. An experimental study in rabbits. J Bone Joint Surg Br. 1981;63:185–189.[PubMed]
  • 17. Altman RD, et al Effect of nonsteroidal antiinflammatory drugs on fracture healing: a laboratory study in rats. J Orthop Trauma. 1995;9:392–400.[PubMed][Google Scholar]
  • 18. Ho ML, Chang JK, Wang GJEffects of ketorolac on bone repair: a radiographic study in modeled demineralized bone matrix grafted rabbits. Pharmacology. 1998;57:148–159.[PubMed][Google Scholar]
  • 19. Giannoudis PV, et al. Nonunion of the femoral diaphysis. The influence of reaming and non-steroidal anti-inflammatory drugs. J Bone Joint Surg Br. 2000;82:655–658.[PubMed]
  • 20. Glassman SD, et al The effect of postoperative nonsteroidal anti-inflammatory drug administration on spinal fusion. Spine. 1998;23:834–838.[PubMed][Google Scholar]
  • 21. Keller J, Klamer A, Bak B, Suder PEffect of local prostaglandin E2 on fracture callus in rabbits. Acta Orthop Scand. 1993;64:59–63.[PubMed][Google Scholar]
  • 22. Keller JEffects of indomethacin and local prostaglandin E2 on fracture healing in rabbits. Dan Med Bull. 1996;43:317–329.[PubMed][Google Scholar]
  • 23. Norrdin RW, Shih MSSystemic effects of prostaglandin E2 on vertebral trabecular remodeling in beagles used in a healing study. Calcif Tissue Int. 1988;42:363–368.[PubMed][Google Scholar]
  • 24. Einhorn TAThe cell and molecular biology of fracture healing. Clin Orthop. 1998;355(Suppl.):7–21.[PubMed][Google Scholar]
  • 25. Barnes GL, Kostenuik PJ, Gerstenfeld LC, Einhorn TAGrowth factor regulation of fracture repair. J Bone Miner Res. 1999;14:1805–1815.[PubMed][Google Scholar]
  • 26. Zhang X, Morham SG, Langenbach R, Young DAMalignant transformation and antineoplastic actions of nonsteroidal antiinflammatory drugs (NSAIDs) on cyclooxygenase-null embryo fibroblasts. J Exp Med. 1999;190:451–459.[Google Scholar]
  • 27. Le AX, Miclau T, Hu D, Helms JAMolecular aspects of healing in stabilized and non-stabilized fractures. J Orthop Res. 2001;19:78–84.[PubMed][Google Scholar]
  • 28. Ferguson CM, Miclau T, Hu D, Alpern E, Helms JACommon molecular pathways in skeletal morphogenesis and repair. Ann NY Acad Sci. 1998;857:33–42.[PubMed][Google Scholar]
  • 29. Bonnarens F, Einhorn TAProduction of a standard closed fracture in laboratory animal bone. J Orthop Res. 1984;2:97–101.[PubMed][Google Scholar]
  • 30. Flick, L.M.H., Boyce, J.L., and Schwarz, E.M. 2001. Improved identification of fracture callus using alcian blue hematoxylin and orange G/Eoroin counterstain. J. Histotech. In press.
  • 31. Boyce BF, Aufdemorte TB, Garrett IR, Yates AJ, Mundy GREffects of interleukin-1 on bone turnover in normal mice. Endocrinology. 1989;125:1142–1150.[PubMed][Google Scholar]
  • 32. Dunstan CR, et al Systemic administration of acidic fibroblast growth factor (FGF-1) prevents bone loss and increases new bone formation in ovariectomized rats. J Bone Miner Res. 1999;14:953–959.[PubMed][Google Scholar]
  • 33. Schwarz EM, et al A quantitative small animal surrogate to evaluate drug efficacy in preventing wear debris-induced osteolysis. J Orthop Res. 2000;18:849–855.[PubMed][Google Scholar]
  • 34. Probst A, Spiegel HUCellular mechanisms of bone repair. J Invest Surg. 1997;10:77–86.[PubMed][Google Scholar]
  • 35. Bruder SP, Fink DJ, Caplan AIMesenchymal stem cells in bone development, bone repair, and skeletal regeneration therapy. J Cell Biochem. 1994;56:283–294.[PubMed][Google Scholar]
  • 36. de Crombrugghe B, Lefebvre V, Nakashima KRegulatory mechanisms in the pathways of cartilage and bone formation. Curr Opin Cell Biol. 2001;13:721–727.[PubMed][Google Scholar]
  • 37. Gerstenfeld L, et al Differential inhibition of fracture healing by non-specific and cyclooxygenase-2 (COX-2) specific non-steroidal anti-inflammatory drugs. Trans Orthop Res Soc. 2002;27:0239. (Abstr.) [PubMed][Google Scholar]
  • 38. O’Keefe R, Puzas J, Loveys L, Hicks D, Rosier RAnalysis of type II and type X collagen synthesis in cultured growth plate chondrocytes by in situ hybridization: rapid induction of type X collagen in culture. J Bone Miner Res. 1994;9:1713–1722.[PubMed][Google Scholar]
  • 39. Wu C, et al Proteolysis involving matrix metalloproteinase 13 (collagenase-3) is required for chondrocyte differentiation that is associated with matrix mineralization. J Bone Miner Res. 2002;17:639–651.[PubMed][Google Scholar]
  • 40. Rodan SB, Wesolowski G, Thomas K, Rodan GAGrowth stimulation of rat calvaria osteoblastic cells by acidic fibroblast growth factor. Endocrinology. 1987;121:1917–1923.[PubMed][Google Scholar]
  • 41. Kotev-Emeth S, Savion N, Pri-chen S, Pitaru SEffect of maturation on the osteogenic response of cultured stromal bone marrow cells to basic fibroblast growth factor. Bone. 2000;27:777–783.[PubMed][Google Scholar]
  • 42. Weinreb M, Grosskopf A, Shir NThe anabolic effect of PGE2 in rat bone marrow cultures is mediated via the EP4 receptor subtype. Am J Physiol. 1999;276:E376–E383.[PubMed][Google Scholar]
  • 43. Kaneki H, et al Prostaglandin E2 stimulates the formation of mineralized bone nodules by a cAMP-independent mechanism in the culture of adult rat calvarial osteoblasts. J Cell Biochem. 1999;73:36–48.[PubMed][Google Scholar]
  • 44. Tang LY, Kimmel DB, Jee WS, Yee JAFunctional characterization of prostaglandin E2 inducible osteogenic colony forming units in cultures of cells isolated from the neonatal rat calvarium. J Cell Physiol. 1996;166:76–83.[PubMed][Google Scholar]
  • 45. Nagata T, et al Effect of prostaglandin E2 on mineralization of bone nodules formed by fetal rat calvarial cells. Calcif Tissue Int. 1994;55:451–457.[PubMed][Google Scholar]
  • 46. Flanagan AM, Chambers TJStimulation of bone nodule formation in vitro by prostaglandins E1 and E2. Endocrinology. 1992;130:443–448.[PubMed][Google Scholar]
  • 47. Keila S, Kelner A, Weinreb MSystemic prostaglandin E2 increases cancellous bone formation and mass in aging rats and stimulates their bone marrow osteogenic capacity in vivo and in vitro. J Endocrinol. 2001;168:131–139.[PubMed][Google Scholar]
  • 48. Scutt A, Zeschnigk M, Bertram PPGE2induces the transition from non-adherent to adherent bone marrow mesenchymal precursor cells via a cAMP/EP2-mediated mechanism. Prostaglandins. 1995;49:383–395.[PubMed][Google Scholar]
  • 49. Takiguchi T, et al Effect of prostaglandin E2 on recombinant human bone morphogenetic protein-2-stimulated osteoblastic differentiation in human periodontal ligament cells. J Periodontal Res. 1999;34:431–436.[PubMed][Google Scholar]
  • 50. Paralkar VM, et al Regulation of BMP-7 expression by retinoic acid and prostaglandin E(2) J Cell Physiol. 2002;190:207–217.[PubMed][Google Scholar]
Collaboration tool especially designed for Life Science professionals.Drag-and-drop any entity to your messages.